OpenJournalRank
Compare

Journal rankings · indicator year 2025

Choose a field to open its ranking, or a journal to find its row in its subfield’s list.

Subfield ranking · 2025

Cardiology and Cardiovascular Medicine journal rankings 2025

287 ranked journals · Subfield in Medicine

Cardiology and Cardiovascular Medicine has 287 ranked journals in 2025. The median journal has an OJR of 0.69, below the world average of 1.00, unchanged on 2024; Q1 starts at OJR 1.21. The two highest-scoring journals with stable ranks are Circulation and Journal of the American College of Cardiology: each is likely ranked within the top 3.

Ranks and citation indicators: 2025. Journal access status and listed APC: source snapshot September 23, 2026.

Ranked journals

Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2022–2024, the window the 2025 score is computed on.

287
6% of Medicine
Median OJR

The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.

The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.

The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.

0.69
This subfieldAll 0.78World 1.00
Open-access journals

Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.

45%
All fields: 38%
Median listed APC

Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.

$3,275
Median positive listed APC: $3,275 among 164 journals. Another 6 list $0; 117 have no known price. All fields: $3,200.

Subfields of Medicine (42)

Show all 42 subfields

287 ranked journals

Filters

Quartile

Quartiles split the ranked journals of the list you are viewing into four equal groups by OJR. Q1 is the top quarter and Q4 the bottom quarter.

They are computed within the list on screen, so a journal can be Q1 in its subfield and Q2 in the global ranking.

Access
APC (list price)
Loading every ranked journal in this list…
Cardiology and Cardiovascular Medicine ranking, 2025

Rank is the position by OJR within the list on screen; 1 is the highest.

The small range under it is the likely rank range: in 95% of 1,000 resamples of the journal’s papers, it ranked inside that range. Journals whose ranges overlap are not clearly different.

OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields.

The badge is the journal’s quartile in this list.

OJR

Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field.

▲ or ▼ is the change from 2024. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor.

Citable documents (articles, reviews and conference papers) published in 2022–2024, the window the 2025 OJR is computed on. A journal needs at least 30 to be ranked.

Share of the journal’s 2022–2024 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal.

List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed.

The line is the journal’s OJR from 2016 to 2025.

A label compares the 2022→2025 change with the median change of the journal’s field or domain. Rising needs a relative change of +10% or more that is at least 2 standard errors above zero; Falling needs -9.1% or less (rounded), at least 2 standard errors below zero. Sorting uses that relative change.

Compare
Rank 1; likely between #1 and #1 of 287CirculationLippincott Williams & Wilkins · United States
8.59Q125.08 2.29 up from 20241,3195%—Rising vs field, 2022–25
Rank 2; likely between #2 and #3 of 287Journal of the American College of CardiologyElsevier BV · United States
5.77Q113.27 1.07 down from 20241,60379%$7,166
Rank 3; likely between #2 and #4 of 287European Heart JournalOxford University Press · United Kingdom
5.35Q115.89 2.06 up from 20242,10813%$5,922
Rank 4; likely between #3 and #6 of 287Nature Reviews CardiologyNature Portfolio · United Kingdom
4.13Q119.21 3.54 up from 202442223%—
Rank 5; likely between #3 and #11 of 287Cardiovascular ResearchOxford University Press · United Kingdom
3.74Q110.10 1.89 down from 202453871%$5,329Rising vs field, 2022–25
Rank 6; likely between #5 and #10 of 287JAMA CardiologyAmerican Medical Association · United States
3.35Q18.30 1.10 up from 202470450%—
Rank 7; likely between #2 and #43 of 287Cardiac failure reviewOAUnited Kingdom
3.12Q112.73 6.26 up from 202468100%$2,146
Rank 8; likely between #7 and #14 of 287HypertensionLippincott Williams & Wilkins · United States
2.89Q18.80 1.20 up from 202478320%—Rising vs field, 2022–25
Rank 9; likely between #5 and #25 of 287Progress in Cardiovascular DiseasesElsevier BV · United States
2.84Q19.31 2.49 up from 202426528%$4,130
Rank 10; likely between #6 and #23 of 287JAMA Internal MedicineAmerican Medical Association · United States
2.76Q17.14 0.37 up from 20241,23740%—
Rank 11; likely between #7 and #21 of 287Circulation Arrhythmia and ElectrophysiologyLippincott Williams & Wilkins · United States
2.74Q16.89 0.66 down from 202428154%—Rising vs field, 2022–25
Rank 12; likely between #8 and #22 of 287EP EuropaceOxford University Press · United Kingdom
2.63Q18.51 1.23 up from 2024875100%$4,909Rising vs field, 2022–25
Rank 13; likely between #7 and #27 of 287Circulation Cardiovascular Quality and OutcomesLippincott Williams & Wilkins · United States
2.60Q15.52 0.03 up from 202430650%—
Rank 14; likely between #9 and #23 of 287Basic Research in CardiologySpringer Nature · Germany
2.57Q19.42 1.08 up from 202418277%$4,990
Rank 15; likely between #7 and #30 of 287Current Hypertension ReportsSpringer Science+Business Media · United States
2.53Q17.20 0.90 up from 202415253%$4,590Rising vs field, 2022–25
Rank 16; likely between #9 and #26 of 287JACC CardioOncologyOAElsevier BV · United States
2.53Q17.12 0.09 up from 2024303100%$4,200Rising vs field, 2022–25
Rank 17; likely between #10 and #24 of 287Circulation Cardiovascular InterventionsLippincott Williams & Wilkins · United States
2.51Q16.26 0.08 up from 202432726%—
Rank 18; likely between #6 and #38 of 287Journal of the Renin-Angiotensin-Aldosterone SystemSAGE Publishing · United Kingdom
2.51Q110.24 5.36 up from 20244012%$4,150
Rank 19; likely between #8 and #33 of 287American Journal of Preventive CardiologyOAElsevier BV · Netherlands
2.39Q15.20 0.92 down from 2024240100%$1,900Rising vs field, 2022–25
Rank 20; likely between #8 and #34 of 287Annual Review of MedicineAnnual Reviews · United States
2.37Q114.92 0.12 up from 202410297%—
Rank 21; likely between #11 and #29 of 287European Journal of Preventive CardiologyOxford University Press · United Kingdom
2.33Q17.24 1.90 up from 202478075%$3,792Rising vs field, 2022–25
Rank 22; likely between #6 and #43 of 287Trends in Cardiovascular MedicineElsevier BV · United States
2.29Q15.74 2.02 down from 202411325%$4,740
Rank 23; likely between #14 and #30 of 287JACC. Cardiovascular imagingElsevier BV · Netherlands
2.28Q16.99 1.00 up from 202471267%$5,000Rising vs field, 2022–25
Rank 24; likely between #19 and #27 of 287Journal of the American Heart AssociationOAWiley · United States
2.22Q15.99 0.59 up from 20243,078100%$3,810
Rank 25; likely between #16 and #32 of 287European Journal of Heart FailureElsevier BV · Netherlands
2.17Q16.69 0.29 down from 20241,04369%$5,300Falling vs field, 2022–25
Rank 26; likely between #6 and #52 of 287Global HeartOAElsevier BV · United Kingdom
2.16Q16.38 2.41 up from 2024244100%$3,300Rising vs field, 2022–25
Rank 27; likely between #17 and #32 of 287EuroInterventionEuropean Association of Percutaneous Cardiovascular Interventions · France
2.14Q15.02 0.38 down from 202464085%—Rising vs field, 2022–25
Rank 28; likely between #19 and #35 of 287European Heart Journal - Cardiovascular ImagingOxford University Press · United Kingdom
2.05Q15.52 0.04 down from 202451741%$5,203
Rank 29; likely between #22 and #36 of 287JACC Heart FailureElsevier BV · Netherlands
2.00Q15.51 0.05 up from 202469470%$5,000
Rank 30; likely between #9 and #61 of 287Clinical HypertensionOABioMed Central · United Kingdom
1.98Q17.21 2.76 up from 2024109100%$0 listed
Rank 31; likely between #23 and #37 of 287Circulation Heart FailureLippincott Williams & Wilkins · United States
1.96Q15.24 0.22 down from 202438348%—
Rank 32; likely between #17 and #56 of 287Medical Clinics of North AmericaElsevier BV · United States
1.83Q13.77 0.70 down from 20242647%$3,350Falling vs field, 2022–25
Rank 33; likely between #8 and #92 of 287Mayo Clinic Proceedings Innovations Quality & OutcomesOAElsevier BV · United States
1.83Q15.25 2.31 up from 2024175100%$3,000
Rank 34; likely between #28 and #39 of 287JACC: Cardiovascular InterventionsElsevier BV · United States
1.82Q14.84 0.54 up from 20241,42983%$5,000
Rank 35; likely between #29 and #49 of 287Circulation Cardiovascular ImagingLippincott Williams & Wilkins · United States
1.71Q14.85 0.97 up from 202437733%—Rising vs field, 2022–25
Rank 36; likely between #32 and #51 of 287Current Cardiology ReportsSpringer Science+Business Media · United States
1.63Q14.68 0.57 up from 202451649%$4,490
Rank 36; likely between #27 and #57 of 287European Heart Journal - Digital HealthOAOxford University Press · United Kingdom
1.63Q15.63 0.86 up from 2024224100%$3,725Rising vs field, 2022–25
Rank 38; likely between #33 and #53 of 287JACC Basic to Translational ScienceOAElsevier BV · United States
1.60Q14.79 0.22 up from 2024397100%$4,750Falling vs field, 2022–25
Rank 39; likely between #34 and #51 of 287JACC. Clinical electrophysiologyElsevier BV · United States
1.59Q14.21 0.21 down from 202489569%$5,000
Rank 40; likely between #32 and #58 of 287European Heart Journal - Quality of Care and Clinical OutcomesOxford University Press · United Kingdom
1.57Q15.10 0.79 up from 202424237%$4,591
Rank 41; likely between #30 and #65 of 287European Cardiology ReviewOARadcliffe Publishing · United Kingdom
1.57Q14.49 0.60 up from 202498100%$2,146
Rank 42; likely between #33 and #56 of 287Heart Failure ReviewsSpringer Science+Business Media · United States
1.56Q15.74 0.86 up from 202426054%$3,090
Rank 43; likely between #11 and #107 of 287Journal of HypertensionLippincott Williams & Wilkins · United Kingdom
1.52Q15.30 0.26 up from 20248079%—
Rank 44; likely between #29 and #81 of 287Cardiovascular Digital Health JournalOAElsevier BV · United States
1.52Q14.86 1.42 up from 202476—$2,600
Rank 45; likely between #12 and #162 of 287Clinical Medicine Insights CardiologyOASAGE Publishing · United States
1.52Q12.48 2.23 down from 202442100%$2,650
Rank 46; likely between #34 and #64 of 287Current Heart Failure ReportsSpringer Science+Business Media · United States
1.51Q14.35 0.05 up from 202415050%$4,490
Rank 47; likely between #17 and #121 of 287Echo Research and PracticeOABioMed Central · United Kingdom
1.50Q14.82 1.94 up from 202461100%$2,390
Rank 48; likely between #33 and #70 of 287Journal of the American Society of EchocardiographyElsevier BV · United States
1.48Q14.90 1.34 up from 202451331%$3,800
Rank 49; likely between #31 and #84 of 287Clinical and Experimental HypertensionOAInforma · United States
1.47Q16.98 3.06 up from 2024170100%—Rising vs field, 2022–25
Rank 50; likely between #35 and #76 of 287Cardiovascular Intervention and TherapeuticsSpringer Science+Business Media · Japan
1.43Q14.07 0.54 up from 202423735%$4,090Rising vs field, 2022–25

The endpoints below each rank show its likely range. How rank ranges are calculated

Citations made in 2025. Corpus-wide, 84.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.

32 additional Cardiology and Cardiovascular Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2022–2024, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.

Rising journals

At a glance

Indicator year: 2025. Publication window: 2022–2024. How these summaries are calculated

Ranked journals
287
Window papers (baseline)
138,818 +2.8% from indicator year 2022
Median OJR
0.694 +2.5% from indicator year 2022
Rising journals (2025)
29

Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2022–2024 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.

Category by indicator year
MeasureYear series20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025
Ranked journals100111124128136139150162173184190200209218227238248266280290294297296293289287
Window papers (baseline)38,50443,22145,69148,56750,28554,81960,68766,01171,20678,67483,57288,87290,96295,515101,247105,471109,295111,295114,960118,626123,446129,250135,096137,746137,659138,818
Median OJR0.480.510.530.660.650.7170.67710.6840.6660.740.790.800.770.780.760.730.7240.6820.6680.6780.7180.6740.67690.700.6910.694

How to read these rankings

OJR, the OpenJournalRank Indicator
A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
Quartiles
Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
Impact factor (2-year)
Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
Rank ranges
Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.